Target intelligence / Profile preview

VPS51 pseudogene 13 (VPS51P13)

Target: VPS51P13
Molecular classification: Other (Pseudogene; not a member of families like receptor, transporter, enzyme, etc.)

Overview

VPS51 pseudogene 13 (VPS51P13) is a non-functional pseudogene derived from the functional gene VPS51. Unlike VPS51, which is a subunit of Golgi-associated retrograde protein (GARP) complex involved in endosomal-lysosomal transport, VPS51P13 does not encode a protein and has no direct role in cellular physiology or disease mechanisms as a therapeutic target. Pseudogenes arise through gene duplication or retrotransposition, and while some can modulate gene expression at the RNA level, VPS51P13 has not been reported to have such activity[2]. It should not be used as a canonical molecular target for drug development or biomarker studies.

Other names: VPS51P13VPS51 pseudogene 13

Beyond the preview

Go deeper on VPS51 pseudogene 13 (VPS51P13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VPS51 pseudogene 13 (VPS51P13).

Explore the full profile